Your browser doesn't support javascript.
loading
Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials.
Mkhize, Nonhlanhla N; Yssel, Anna E J; Kaldine, Haajira; van Dorsten, Rebecca T; Woodward Davis, Amanda S; Beaume, Nicolas; Matten, David; Lambson, Bronwen; Modise, Tandile; Kgagudi, Prudence; York, Talita; Westfall, Dylan H; Giorgi, Elena E; Korber, Bette; Anthony, Colin; Mapengo, Rutendo E; Bekker, Valerie; Domin, Elizabeth; Eaton, Amanda; Deng, Wenjie; DeCamp, Allan; Huang, Yunda; Gilbert, Peter B; Gwashu-Nyangiwe, Asanda; Thebus, Ruwayhida; Ndabambi, Nonkululeko; Mielke, Dieter; Mgodi, Nyaradzo; Karuna, Shelly; Edupuganti, Srilatha; Seaman, Michael S; Corey, Lawrence; Cohen, Myron S; Hural, John; McElrath, M Juliana; Mullins, James I; Montefiori, David; Moore, Penny L; Williamson, Carolyn; Morris, Lynn.
Afiliação
  • Mkhize NN; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
  • Yssel AEJ; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Kaldine H; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • van Dorsten RT; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
  • Woodward Davis AS; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Beaume N; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
  • Matten D; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Lambson B; South African Medical Research Council Antiviral Gene Therapy Research Unit, School of Pathology, Faculty of Health Sciences University of the Witwatersrand, Johannesburg, South Africa.
  • Modise T; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
  • Kgagudi P; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • York T; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Westfall DH; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
  • Giorgi EE; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Korber B; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
  • Anthony C; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Mapengo RE; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
  • Bekker V; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Domin E; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Eaton A; Department of Microbiology, University of Washington, Seattle, Washington, United States of America.
  • Deng W; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
  • DeCamp A; Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America.
  • Huang Y; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Gilbert PB; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
  • Gwashu-Nyangiwe A; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Thebus R; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
  • Ndabambi N; Department of Surgery, Duke University, Durham, North Carolina, United States of America.
  • Mielke D; Department of Surgery, Duke University, Durham, North Carolina, United States of America.
  • Mgodi N; Department of Microbiology, University of Washington, Seattle, Washington, United States of America.
  • Karuna S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
  • Edupuganti S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
  • Seaman MS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
  • Corey L; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Cohen MS; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Hural J; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • McElrath MJ; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Mullins JI; Department of Surgery, Duke University, Durham, North Carolina, United States of America.
  • Montefiori D; University of Zimbabwe College of Health Sciences Clinical Trials Research Centre, Harare, Zimbabwe.
  • Moore PL; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
  • Williamson C; Division of Infectious Diseases, Department of Medicine, Emory University, Decatur, Georgia, United States of America.
  • Morris L; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
PLoS Pathog ; 19(6): e1011469, 2023 06.
Article em En | MEDLINE | ID: mdl-37384759
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Soropositividade para HIV Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: PLoS Pathog Ano de publicação: 2023 Tipo de documento: Article País de afiliação: África do Sul
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Soropositividade para HIV Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: PLoS Pathog Ano de publicação: 2023 Tipo de documento: Article País de afiliação: África do Sul